Faculty
Kyung Won Seo
Director General, National Institute of Food and Drug Safety Evaluation, Ministiry of Food and Drug Safety, Korea, Republic of
Dr. Kyung Won Seo is the Director General of the National Institute of Food and Drug Safety Evaluation at the Ministiry of Food and Drug Safety Korea since February 2021. Dr. Seo has involved in many toxicological research and studies and reviewed non-clinical data for 15 years. Dr. Seo was in charge of several divisions as Director including metabolic, reproductive and respiratory product; antibiotics and oncology product; and bioequivalence evaluation. Prior to her current position, Dr. Seo served as Director General of Pharmaceutical and Medical Device Research Department from 2015 to 2019.
Gerald Dal Pan, MD, MHS
Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Gerald J. Dal Pan, MD, MHS currently serves as the Director of the Office of Surveillance and Epidemiology in FDA’s Center for Drug Evaluation and Research, where since 2005 he has been responsible for the Center’s programs in adverse event surveillance and analysis, pharmacoepidemiology, risk management, and medication error prevention. In this capacity, he is involved in both the premarket and postmarket regulation of drugs and therapeutic biologics, and in the implementation of the drug safety provisions of the Food and Drug Administration Amendments Act and other initiatives.
Euna Han
Professor, Yonsei University, Korea, Republic of
Hannah Jeon
Cluster Head APAC, Roche , Korea, Republic of
Yasufumi Kuroda, PhD
Associate Director, PV Dept., Daiichi Sankyo Company, Limited, Japan
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, International Labeling, Pfizer R&D Japan G.K., Japan
Rie Matsui is Senior Director, Regional Labeling Head for APAC, International Labeling Group, Global Regulatory Science, Pfizer Japan. She is also the Head, External Engagements for ILG. She is the founder of Asia Labeling Hub at Pfizer that has created various local label updates for more than 25 countries in Asia. She was a member of the Advisory Council of DIA Japan until 2020 and received the DIA Japan regional award in 2015. Her papers were published in scientific journals such as Therapeutic Innovation & Regulatory Science. She is the vice chair of the 2021 DIA Japan Annual Meeting Program Committee. She received DIA Global Inspire Award Connector in 2022. She is teaching at Keio University and Chiba University and is a pharmacist.
Mohit Raizada
Pharmacovigilance Manager and India Lead for Signal Management Services , IQVIA, India
Dawn Ren
Head of Therapeutic Area Speciality Medicine , Bayer Healthcare Company Limited, China
Shuya Yoshida
Reviewer, Office of New Drug I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chul Kim, MD, PhD
Vice President, Samsung Bioepis, Korea, Republic of
Manabu Akazawa
Professor Public Health and Epidemiology, Meiji Pharmaceutical University, Japan
Seungjae Baek
Excutive Director, Hanmi Pharmaceuticals, Korea, Republic of
Junjeong Choi
Associate Professor- Department of Pharmacy, Yonsei University College of Pharmacy, Korea, Republic of
Sanghee Kim
Chief Executive Officer, Novotech Asia Korea Ltd., Korea, Republic of
MinJung Lim, MPharm
Managing director, MediSafe, Pharmacovigilance Services, Korea, Republic of
Yongseok Ko
Deputy Director NIFDS, Ministry of Food and Drug Safety (MFDS), Korea, Republic of
Eunah Paek
Head of Medical Operation Group, Boryung Pharmaceutical Company, Korea, Republic of
SuWon Kim
Pharmacovigilance Manager, Dong-A-ST, Korea, Republic of
HyeYoung Kim
Medical Information & Pharmacoviglance, Chong Kun Dang Pharm, Korea, Republic of
Mijeong Kim, PhD
Medical advisor, C&R Research Inc., Korea, Republic of
SoYeon Park
Senior Drug Safety Manager , Celgene, Korea, Republic of
Hwayoung Lee
Team Lead APAC, Pfizer Pharmaceuticals, Korea, Republic of
Have an account?